Yawn Barbara P, Merrill Debora D, Martinez Sergio, Callen Elisabeth, Cotton Janice, Williams Dennis, Loskutova Natalia Y
COPD Foundation, Miami, FL 33134, USA.
Department of Family and Community Health, University of Minnesota, Minneapolis, MN 55455, USA.
Vaccines (Basel). 2022 Mar 10;10(3):420. doi: 10.3390/vaccines10030420.
Herpes zoster (HZ) is common in older adults with conditions such as chronic obstructive pulmonary disease (COPD). Effective prevention is available through vaccination, but HZ vaccine uptake remains incomplete. Using an online survey of people with self-reported COPD, ShiPPS assessed HZ risk awareness, HZ vaccine use and barriers, and the impact of an HZ educational video on vaccine intent. USA members of the COPD Foundation’s Patient-Powered Research Network aged >50 years were surveyed in fall 2020. The responses were analyzed using descriptive and comparative statistics. Of the 735 respondents (59.6% female, mean age 68.5 years), 192 (26.1%) reported previous HZ, of whom 49 (25.5%) reported increased COPD symptoms during HZ episodes. Most participants (94.0%) knew of HZ vaccines, but only 33.1% reported receiving the Advisory Committee on Immunization Practices-preferred recombinant HZ vaccination. The recall of receiving HZ vaccine recommendations differed by the site attended: 68.8% primary care, 26.6% pulmonology offices. Most (74.7%) were unaware that COPD increases HZ risk. Among unvaccinated participants, interest in getting the HZ vaccine increased from 32.0% to 73.5% after watching the video. These results highlight the need for people with COPD to receive further HZ education, such as the five-minute video, and HZ vaccine recommendations from healthcare professionals.
带状疱疹（HZ）在患有慢性阻塞性肺疾病（COPD）等疾病的老年人中很常见。通过接种疫苗可实现有效预防，但HZ疫苗的接种率仍不完整。ShiPPS通过对自我报告患有COPD的人群进行在线调查，评估了HZ风险意识、HZ疫苗使用情况及障碍，以及一部HZ教育视频对疫苗接种意愿的影响。2020年秋季，对慢性阻塞性肺疾病基金会患者驱动研究网络中年龄大于50岁的美国成员进行了调查。使用描述性和比较性统计方法对回答进行了分析。在735名受访者中（59.6%为女性，平均年龄68.5岁），192人（26.1%）报告曾患过HZ，其中49人（25.5%）报告在HZ发作期间COPD症状加重。大多数参与者（94.0%）知道HZ疫苗，但只有33.1%的人报告接种了免疫实践咨询委员会推荐的重组HZ疫苗。对接受HZ疫苗推荐的回忆因就诊地点而异：68.8%来自初级保健机构，26.6%来自肺病科诊所。大多数人（74.7%）不知道COPD会增加HZ风险。在未接种疫苗的参与者中，观看视频后接种HZ疫苗的意愿从32.0%提高到了73.5%。这些结果凸显了COPD患者需要接受进一步的HZ教育，如这部五分钟的视频，以及医疗保健专业人员的HZ疫苗推荐。
